TB Research

Infantile Disseminated Bacille Calmette-Guérin Disease with Hemophagocytosis and Mimicking Juvenile Myelomonocytic Leukemia: A Case Report with Concise Literature Review

Godkhindi VM, Gupta N, Gupta N, Bhat KV, Venkatagiri AM

International journal of mycobacteriology · 2024-04

Abstract

Bacille Calmette-Guérin (BCG) is a live-attenuated vaccine routinely administered to newborns to prevent severe forms of tuberculosis (TB) in TB-endemic countries. Disseminated BCG vaccine disease is a classic feature of children with human immunodeficiency virus (HIV) or primary immunodeficiency disorders (PIDs) and is associated with high mortality. We report a case of a 6-month-old infant with disseminated BCG disease and hemophagocytic lymphohistiocytosis mimicking juvenile myelomonocytic leukemia with no demonstrable features of HIV or PID even after extensive laboratory work-up and succumbed to progressive disease. Disseminated BCG disease is a rare and potentially fatal complication of BCG vaccine, and prompt immunological evaluation complemented by initiation of 4-drug antitubercular therapy and definitive treatment with antiretroviral therapy or hematopoietic stem cell transplant is warranted.

MeSH terms

  • Humans
  • Mycobacterium bovis
  • Tuberculosis
  • BCG Vaccine
  • Antitubercular Agents
  • Diagnosis, Differential
  • Fatal Outcome
  • Infant
  • Male
  • Lymphohistiocytosis, Hemophagocytic
  • Leukemia, Myelomonocytic, Juvenile